AMPH

Amphastar Pharmaceuticals (AMPH)

About Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Details

Daily high

$19.58

Daily low

$18.50

Price at open

$18.61

52 Week High

$31.26

52 Week Low

$16.64

Market cap

808.2M

Dividend yield

0.00%

Volume

660,872

Avg. volume

653,151

P/E ratio

11.01

Amphastar Pharmaceuticals News